Related Experiment Video
Updated: May 4, 2026

06:46
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
11.4K
"A feeling that you're helping": proxy decision making for Alzheimer's research
Narrative Inquiry in Bioethics
|January 11, 2014
Summary
Proxy decision-makers for dementia patients consider direct benefits, altruism, and trust when consenting to research. They also weigh risks, inconvenience, and illness stage, using both substituted judgment and best interests standards.
Area of Science:
- Medical ethics
- Neuroscience
- Clinical research
Background:
- Surrogate decision-makers are crucial for research involving individuals with dementia who lack decision-making capacity.
- Understanding the decision-making processes of these proxies is essential for ethical research conduct.
Purpose of the Study:
- To investigate the factors influencing surrogate (proxy) decision-makers' consent for research participation of individuals with Alzheimer's disease (AD).
- To explore how proxies weigh potential risks and benefits when making research decisions for patients with diminished capacity.
Main Methods:
- Random assignment of 82 proxies for AD patients to one of three hypothetical research protocols with varying risk/benefit levels.
- Proxies answered questions regarding perceived patient and societal benefits, willingness to enroll, and rationale for their decisions.
Main Results:
- Proxies citing reasons for enrollment emphasized potential direct patient benefit, altruism, and trust in researchers.
- Proxies declining enrollment cited concerns about risks, inconvenience, and the patient's illness stage.
- Decision-making incorporated both substituted judgment (patient's likely preference) and best interests standards.
Conclusions:
- Proxy decision-making for research in dementia is complex, involving multiple factors.
- Findings can inform policies and guidelines for informed consent in research involving vulnerable populations.
- Further research is needed to fully understand the influences on and adequacy of proxy decision-making.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Decision Making: Traditional Method
4.4K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
4.4K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Egoism and Altruism
91.3K
Voluntary behavior with the intent to help other people is called prosocial behavior. Why do people help other people? Is personal benefit such as feeling good about oneself the only reason people help one another?
91.3K
Ethical Dilemmas II
2.7K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.7K

